Imaging Technologies and Diagnostic tests of Biomarkers


In clinical trials using imaging, biomarkers and response criteria are used to assess the tumor evolution with therapy. Imaging biomarkers are often root contributors to a clinical trial’s endpoints, but they are not the same. Diagnostic tests and the biological biomarker (biomarkers) they measure are often classified based on the circumstances under which they are used. Biomarkers provide information about a patient at virtually every stage of care. They can help doctors evaluate the likelihood that a patient will develop a disease, diagnose a disorder, evaluate the severity of a disorder and/or its likely progression, determine optimal treatment strategies and monitor response to treatment.


    Related Conference of Imaging Technologies and Diagnostic tests of Biomarkers

    Imaging Technologies and Diagnostic tests of Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in